Back to catalog
Reta30 mg
Metabolic Research
Reta 30 mg
Synthetic peptide — GIP / GLP-1 / glucagon receptor tri-agonist
$140
Quantity supplied: 30 mg per vial
For research use only • Not for human or veterinary consumption
Research overview
Retatrutide, a synthetic tri-agonist peptide investigated in published literature at the GIP, GLP-1, and glucagon receptors.
- Incretin receptor signalling in in-vitro and animal models
- Glucose homeostasis and energy-balance research
- Comparative receptor-selectivity studies
Descriptions reference published scientific literature and are provided for research context only. No medical, therapeutic, or performance claims are made.
Certificate of analysis
Documentation coming soon. Contact us for available batch documentation for this compound.